FIELD: organic chemistry. SUBSTANCE: claimed invention describes heterocyclic nitrogen containing compounds of formula I: $$$ wherein X is oxygen or sulfur; Y is carbon or nitrogen; Z is carbon or nitrogen, Y and Z simultaneously are not nitrogen; $$$ and $$$ are independently hydrogen, alkyl containing 1 to 6 carbon atoms, halogen, trifluoromethyl, nitrile, alkoxy containing 1 to 6 carbon atoms, $$$ wherein $$$ is hydrogen or alkyl containing 1 to 6 carbon atoms, $$$ wherein $$$ and $$$ are independently hydrogen, alkyl containing 1 to 3 carbon atoms, methoxy or together with nitrogen form morphiline, pyrrolidine or piperidino, $$$ wherein $$$ and $$$ are hydrogen or alkyl containing 1 to 6 carbon atoms, $$$ wherein $$$ is alkyl containing 1 to 6 carbon atoms.$$$ wherein is as defined above, $$$ wherein $$$ is as defined above. $$$ wherein $$$ is as defined above, and $$$ wherein $$$ and $$$ are independently hydrogen or alkyl containing 1 to 6 carbon atoms; $$$ is methyl, cyclohexyl, phenyl, unsubstituted or substituted with residues of group consisting of halogen, trifluoromethyl, alkyl containing from 1 to 4 carbon atoms and alkoxy containing 1 to 4 carbon atom; $$$ wherein $$$ is as defined above, $$$ wherein $$$ is as defined above, $$$ wherein $$$ is as defined above wherein $$$ and $$$ are as defined above, nitro, 1- piperidinyl, 2-, 3- or 4-pyridine, morpholine, thiomorphaline, pyrrolidine, imidazole unsubstituted or substituted at nitrogen with alkyl containing 1 to 4 carbon along, 2-thiazole, 2-methyl-4-thiazole, dialkylamine containing 1 to 4 carbon atoms in each alkyl group or alkyl ether containing 1 to 4 carbon atoms; $$$ is ester of formula wherein $$$ is alkyl containing 1 to 4 carbon atoms; $$$ is ester of formula wherein $$$ is alkyl containing 1 to 4 carbon atoms, amide of formula: $$$ wherein $$$ and $$$ are independently hydrogen, alkyl containing 1 or 2 carbon atoms, methoxy or together with nitrogen form morpholine, piperidine or pyrrolidine, phenyl unsubstituted or substituted with residues of group consisting of halogen, alkyl containing 1 to 4 carbon atoms and alkoxy containing 1 to 4 carbon atoms, 3 methyl-1,2,4-oxadiazol-5-yl, 2-or 3-thienyl, 2-, 3- or 4- pyridyl, 4-pyrazolyl, 2-imidazole unsubstituted or substituted in position 4 with methyl; ketone of formula: $$$ wherein $$$ is alkyl, containing 1 to 3 carbon atoms, phenyl or 1-methylimidazol-2yl, ether of formula: $$$ wherein $$$ is alkyl containing 1 to 3 carbon atoms, thioether of formula wherein $$$ is as defined above. $$$, amine of formula: $$$ wherein $$$ is as defined above, residue of formula: $$$ wherein $$$ is methyl, amino or methylamino, $$$ wherein Me is methyl or carbamate of formula: $$$, $$$ and $$$ are independently hydrogen or methyl; n is 0, 1 or 2, provided that said substituents are not defined as Y and Z are carbon, $$$ and $$$ are hydrogen, halogen, alkyl containing 1 to 4 carbon atoms, alkoxy containing 1 to carbon atoms, cyano, nitro, trifluoromethyl; $$$ is unsubstituted phenyl and $$$ is $$$ wherein $$$ is hydrogen, alkyl, alkenyl or alkynyl, $$$ wherein $$$ and $$$ are hydrogen, alkyl containing 1 to 6 carbon atoms, phenyl, alkoxy or together with nitrogen form pyrrolidine or morpholine, cyano or $$$ or Y and Z are carbon; $$$ is $$$; $$$ and $$$ are hydrogen and $$$ is hydrogen and $$$ is 4- oxyphenyl unsubstituted phenyl and 4-imidazol as racemates or individual enantiomers and salts thereof which are lenkotriene bioxynthesis inhibitors. EFFECT: improved properties of the title compounds. 18 tbl
Title | Year | Author | Number |
---|---|---|---|
PYRAZINE DERIVATIVES AND THEIR ACID-ADDITIVE SALTS | 1992 |
|
RU2124008C1 |
DERIVATIVES OF DIPYRIDO-DIAZEPINE AND THEIR PHARMACOLOGICALLY TOLERATED SALTS SHOWING BIOLOGICAL ACTIVITY | 1992 |
|
RU2024522C1 |
DERIVATIVES OF DIPYRIDO-DIAZEPINE AND THEIR HYDRATES SHOWING BIOLOGICAL ACTIVITY | 1992 |
|
RU2040527C1 |
SUBSTITUTED BENZAMIDINE DERIVATIVES | 1995 |
|
RU2159228C2 |
THIENYLCARBOXYLIC ACID AND AMINOALCOHOLS ESTERS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING ANTICHOLINERGIC ACTIVITY | 1990 |
|
RU2073677C1 |
ANNEALED DIHYDROPYRIDINE DERIVATIVES OR SALTS THEREOF WITH PHYSIOLOGICALLY TOLERABLE ACIDS AND AGENT BLOCKING NONSELECTIVE CATIONIC PASSAGES | 1993 |
|
RU2127736C1 |
ISOQUINOLINE DERIVATIVES AND THEIR SALTS | 1994 |
|
RU2136664C1 |
AMIDINE DERIVATIVES, MIXTURE OF THEIR ISOMERS OR SEPARATE ISOMERS AND SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC EFFECT WITH RESPECT TO LEUKOTRIENE-B | 1993 |
|
RU2124002C1 |
2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]-DIAZEPINE-6-ONES, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION SHOWING INHIBITORY ACTIVITY WITH RESPECT TO HIV-1 REVERSE TRANSCRIPTASE | 1995 |
|
RU2142464C1 |
DERIVATIVES OF PHENOL AND COMPOSITION USED FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS GROWTH AND REPLICATION BASED ON THEREOF | 1990 |
|
RU2108785C1 |
Authors
Dates
1997-05-27—Published
1992-09-23—Filed